Ipso-substitution by cytochrome P450 with conversion of p-hydroxybenzene derivatives to hydroquinone:: Evidence for hydroperoxo-iron as the active oxygen species

被引:55
作者
Vatsis, KP [1 ]
Coon, MJ [1 ]
机构
[1] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA
关键词
activated oxygen species; cytochrome P450; ipso-substitution;
D O I
10.1006/abbi.2001.2665
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Evidence for multiple functional active oxidants in cytochrome P450-catalyzed reactions was previously obtained in this laboratory with mutants in which proton delivery was perturbed by replacement of the highly conserved threonine residue in the active site by alanine, thus apparently interfering with the conversion of the peroxo-iron to the hydroperoxo-iron and the latter to the oxenoid-iron species. These enzymes have now been employed to examine the reaction in which cytochrome P450 in liver microsomes is known to effect ipso-substitution, the elimination of p-substituents in phenols to yield hydroquinone : As shown with purified NH2-truncated cytochromes in a reconstituted enzyme system, the reaction exhibits an absolute requirement for cytochrome P450 and NADPH-cytochrome P450 reductase. Under optimal conditions truncated cytochrome P450 2E1 is active with 10 of the p-substituted phenols examined. Of particular interest, the corresponding cytochrome with threonine-303 replaced by alanine is from 1.5- to 50-fold higher in activity with the p-chloro, -bromo, -nitro, -cyano, -hydroxymethyl, -formyl, and -acetyl derivatives, and the reaction with the p-benzoyl, -methyl, and -t-butyl compounds is catalyzed by the mutant enzyme only. The results implicate the hydroperoxoiron species as an electrophilic active oxidant in cytochrome P450-catalyzed aromatic ipso-substitution. (C) 2001 Elsevier Science.
引用
收藏
页码:119 / 129
页数:11
相关论文
共 49 条
[1]   MECHANISTIC STUDIES ON C-19 DEMETHYLATION IN ESTROGEN BIOSYNTHESIS [J].
AKHTAR, M ;
CALDER, MR ;
CORINA, DL ;
WRIGHT, JN .
BIOCHEMICAL JOURNAL, 1982, 201 (03) :569-580
[2]  
Anders MW, 1985, BIOACTIVATION FOREIG, P259
[3]  
Coon MJ, 1998, DRUG METAB DISPOS, V26, P1190
[4]   CYTOCHROME-P450 - PROGRESS AND PREDICTIONS [J].
COON, MJ ;
DING, XX ;
PERNECKY, SJ ;
VAZ, ADN .
FASEB JOURNAL, 1992, 6 (02) :669-673
[5]   STRUCTURE OF CYTOCHROME P450ERYF INVOLVED IN ERYTHROMYCIN BIOSYNTHESIS [J].
CUPPVICKERY, JR ;
POULOS, TL .
NATURE STRUCTURAL BIOLOGY, 1995, 2 (02) :144-153
[6]  
de Montellano P.R. Ortiz., 1995, CYTOCHROME P450 STRU
[7]   PROPERTIES OF NADPH-CYTOCHROME P-450 REDUCTASE PURIFIED FROM RABBIT LIVER-MICROSOMES [J].
FRENCH, JS ;
COON, MJ .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1979, 195 (02) :565-577
[8]  
FURHOP JH, 1976, PORPHYRINS METALLOPO, P757
[9]  
GASSER R, 1988, MOL PHARMACOL, V33, P22
[10]  
GOTOH O, 1989, FRONTIERS BIOTRANSFO, V1, P195